Top of Page
Skip main navigation

Controlled Substance Prescribing in Florida

Registration Details

Register Now

Date/Time:
Thursday, 10/25/18 6:30 PM - 8:30 PM

Format(s):
Lecture

Credit Hours:
2

This 2 hour  Florida Controlled Substance Program is approved by The Florida Academy of Family Physicians. 

COURSE DESCRIPTION

The Florida Controlled Substance Bill (HB 21) requires practitioners to complete a specified board-approved continuing education course to prescribe controlled substances. Each person registered with the DEA and authorized to prescribe controlled substances is required to take a board-approved two-hour continuing education course on prescribing controlled substances. This 2 hour course satisfies the requirements for this new legislation.

COURSE SCHEDULE

  6:00 pm - 6:30 pm    Registration (Light snacks)
  6:30 pm – 8:30 pm   Presentation 

INSTRUCTOR BIO

jason-portnof

Dr. Jason E. Portnof

Dr. Jason E. Portnof is a diplomate of the American Board of Oral and Maxillofacial Surgery and a fellow of the American College of Surgeons (FACS). His interests include the full scope of oral and maxillofacial surgery with an emphasis on the correction of dentofacial deformities, orthognathic surgery (corrective jaw surgery), maxillofacial reconstructive surgery, oral and maxillofacial pathology, and complex dental implantology.

Dr. Portnof graduated with honors from the Nova Southeastern University College of Dental Medicine in Ft. Lauderdale. He earned an MD from Weill Cornell Medical College in New York City, where he was trained in oral and maxillofacial surgery. He received fellowship training in pediatric maxillofacial surgery/craniomaxillofacial surgery at the Royal Children’s Hospital in Melbourne, Australia.  

Dr. Portnof serves as the President of the Florida Cleft Palate Craniofacial Association (FCPA), on the Board of Directors of the Florida Dental Society of Anesthesia (FDSA), and the Florida Society of Oral and Maxillofacial Surgeons Committee on Anesthesia (FSOMS). He is also the pediatric consultant to the American Association of Oral and Maxillofacial Surgeons (AAOMS) Committee on Anesthesia.

Dr. Portnof has authored multiple peer-reviewed articles and presented both nationally and internationally. In addition, he has held numerous teaching positions at prestigious universities including Albert Einstein College of Medicine, Weill Cornell Medical College, Florida Atlantic University, and his alma mater, Nova Southeastern University, where he is the Director of Pediatric Maxillofacial Surgery & Craniomaxillofacial Surgery in the Department of Oral and Maxillofacial Surgery.

EDUCATIONAL OBJECTIVES

Upon completion, participants will be able to:

  • Comply with the Florida Controlled Substance Bill(HB 21) 
  • Educate prescribing dentists regarding the requirements for HB 21 including but not limited to: opioid abuse by establishing prescribing limits, requiring continuing education on controlled substance prescribing, expanding required use of Florida's Prescription Drug Monitoring Program, and EFORCSE
  • Review CDC guidelines for treating acute and chronic pain

 

 

License/Renewal

HB 21 requires each person registered with the DEA and authorized to prescribe controlled substances to take a board-approved two-hour continuing education course on prescribing controlled substances.

ADA CERP - Continuing Education Recognition Program and Association for Continuing Dental Education Logos

Nova Southeastern University Office of Dental Continuing Education Nova Southeastern University is an ADA CERP Recognized Provider.ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual course or instructors, nor does it imply acceptance of credit hour by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.

Return to top of page